FS001

N/A

Report date: 2026/04/23 20:00:25
First In Class

Base Information

Drug NameFS001
Drug Alias NameFS001ESG408FS001/ESG408IPN60300IPN-60300
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker
Mechanisms of ActionDNA topoisomerase I inhibitorsIntegrin alpha-2 antagonists
TargetsDNA topoisomerase IIntegrin alpha-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceSpain +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesYuyan Technology (Beijing) Co LtdShanghai Escugen Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesIpsenYuyan Technology (Beijing) Co LtdIpsen (Shanghai) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A